Evidence map›Paper›PMID 29281739›Full record

ArticlePLoS pathogens2017

Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.

Natalie A Prow, Bing Tang, Joy Gardner, Thuy T Le, Adam Taylor, Yee S Poo, Eri Nakayama, Thiago D C Hirata, Helder I Nakaya, Andrii Slonchak and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Fever: Could A Cardinal Sign of COVID-19 Infection Reduce Mortality?The American journal of the medical sciences · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Natalie A ProwQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Bing TangQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Joy GardnerQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Thuy T LeQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Adam TaylorInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0002-7159-3961
Yee S PooQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Eri NakayamaQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Thiago D C HirataQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-3967-8121
Helder I NakayaSchool of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.ORCID 0000-0001-5297-9108
Andrii SlonchakSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
Pamela MukhopadhyayQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Suresh MahalingamInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0003-3141-8410
Wayne A SchroderQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
William KlimstraDepartment of Microbiology and Molecular Genetics Center for Vaccine Research University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Andreas SuhrbierQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-8986-9025
QIMR Berghofer Medical Research Institute · AUGriffith University · AUUniversidade de São Paulo · BRThe University of Queensland · AUUniversity of Pittsburgh · US

Funding

Molecular Mechanisms of Eastern Equine Encephalitis Virus PathogenesisR01AI095436 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2012 to 2022
$4.5M
NIAID NIH HHS R01 AI095436
6 · The paper itself

Abstract

Chikungunya virus (CHIKV) belongs to a group of mosquito-borne alphaviruses associated with acute and chronic arthropathy, with peripheral and limb joints most commonly affected. Using a mouse model of CHIKV infection and arthritic disease, we show that CHIKV replication and the ensuing foot arthropathy were dramatically reduced when mice were housed at 30°C, rather than the conventional 22°C. The effect was not associated with a detectable fever, but was dependent on type I interferon responses. Bioinformatics analyses of RNA-Seq data after injection of poly(I:C)/jetPEI suggested the unfolded protein response and certain type I interferon responses are promoted when feet are slightly warmer. The ambient temperature thus appears able profoundly to effect anti-viral activity in the periphery, with clear consequences for alphaviral replication and the ensuing arthropathy. These observations may provide an explanation for why alphaviral arthropathies are largely restricted to joints of the limbs and the extremities.

Indexed as

Alphavirus InfectionsAnimalsArthritis, ExperimentalArthritis, InfectiousChikungunya FeverChikungunya virusFemaleFootHost-Pathogen InteractionsHumansInterferon Type IMiceMice, Inbred C57BLMice, KnockoutRoss River virusTemperatureInterferon Type I

Identifiers

PMID29281739
PMCPMC5770078
OpenAlexW2780010183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.